IntrinsicIntrinsic
← Back to Institutions

Davern Capital Partners, LP

15 holdingsFiling period: 2026-06-30Current AUM: $522.5Mestimated from latest prices
#TickerCompanySharesReported ValueCurrent Value% PortfolioChangeDate
1BNTXBiontech SE754.5K$70.2M$65.5M12.54%--2026-06-30
2—Roivant Sciences Ltd1.93M$68.4M$68.4M13.09%--2026-06-30
3—Royalty Pharma PLC1.16M$64.8M$64.8M12.40%--2026-06-30
4IONSIonis Pharmaceuticals Inc798.7K$63.3M$34.7M6.64%--2026-06-30
5INSMInsmed Inc559.8K$59.7M$52.2M10.00%--2026-06-30
6REGNRegeneron Pharmaceuticals92.6K$57.8M$74.8M14.32%--2026-06-30
7LEGNLegend Biotech Corp1.19M$34.4M$24.3M4.65%--2026-06-30
8ALNYAlnylam Pharmaceuticals Inc113.1K$34.0M$25.7M4.93%--2026-06-30
9NTRANatera Inc119.0K$32.3M$48.2M9.22%--2026-06-30
10GPCRStructure Therapeutics Inc446.1K$23.9M$9.4M1.80%--2026-06-30
11MLYSMineralys Therapeutics Inc858.8K$23.2M$17.7M3.38%--2026-06-30
12VERAVera Therapeutics Inc498.8K$21.4M$14.1M2.70%--2026-06-30
13GENBGenerate Biomedicines Inc824.7K$13.9M$10.2M1.95%--2026-06-30
14PRCTProcept Biorobotics Corp464.9K$10.5M$9.2M1.76%--2026-06-30
15AVTXAvalo Therapeutics Inc468.7K$8.7M$3.2M0.61%--2026-06-30
← Scroll →